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Abstract. In vertebrates, a nuclear cap-binding com- 
plex (CBC) formed by two cap-binding proteins, 
CBP20 and CBP80, is involved in several steps of RNA 
metabolism, including pre-mRNA splicing and nuclear 
export of some RNA polymerase II-transcribed U 
snRNAs. The CBC is highly conserved, and antibodies 
against human CBP20 cross-react with the CBP20 
counterpart in the dipteran Chironomus tentans.  Using 
immunoelectron microscopy, the in situ association of 
CBP20 with a specific pre-mRNP particle, the Balbiani 
ring particle, has been analyzed at different stages of 
pre-mRNA synthesis, maturation, and nucleo-cytoplas- 
mic transport. We demonstrate that CBP20 binds to the 
nascent pre-mRNA shortly after transcription initia- 
tion, stays in the RNP particles after splicing has been 
completed, and remains attached to the 5' domain dur- 
ing translocation of the RNP through the nuclear pore 
complex (NPC). The rapid association of CBP20 with 
nascent RNA transcripts in situ is consistent with the 
role of CBC in splicing, and the retention of CBC on 
the RNP during translocation through the NPC sup- 
ports its proposed involvement in RNA export. 
"~'N the nucleus of eukaryotic cells, messenger RNA pre- 
1  /  cursors (pre-mRNAs)  undergo a series of maturation 
-~  reactions before they are exported to the cytoplasm 
where the mature messenger RNAs (mRNAs) can direct 
protein synthesis. One of these maturation events is the 
addition of a  monomethylated guanosine residue to the 
first encoded nucleotide of the RNA via a  5'-5'  triphos- 
phate linkage (Shatkin, 1976). This reaction occurs on all 
transcripts synthesized by RNA polymerase II shortly af- 
ter the start of transcription (Salditt-Georgieff et al., 1980; 
Rasmussen and Lis, 1993). The resulting cap structure is 
implicated in several  aspects of pre-mRNA  and mRNA 
metabolism. The  cap  structure  increases  RNA  stability, 
and  is  required  for  efficient translation  initiation,  pre- 
mRNA splicing, and nuclear export of capped RNAs (Fu- 
ruichi et al., 1977; Shimotohno et al., 1977; Konarska et al., 
1984; Shatkin, 1985; Edery and Sonenberg, 1985; Hamm 
and Mattaj, 1990; Izaurralde et al., 1992). Some of these ef- 
fects are mediated by proteins. In the nucleus, a cap-bind- 
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ing complex (CBC) consisting of two proteins, CBP80 and 
CBP20, has been described (Ohno et al., 1990; Izaurralde 
et al.,  1994, 1995; Kataoka et al.,  1994).  Studies in HeLa 
cell extracts and in Xenopus oocytes have demonstrated 
that CBC mediates efficient splicing of pre-mRNA, proba- 
bly by affecting early stages in spliceosome assembly (Izaur- 
ralde  et  al.,  1994).  In  addition, a  direct  involvement of 
CBC in export of U  snRNAs has recently been demon- 
strated (Izaurralde et al.,  1995).  In the case of mRNA, it 
has been shown that the presence of a 5' cap structure on 
the mRNA enhances its rate of export from the nucleus 
(Hamm and Mattaj,  1990; Jarmolowski et  al.,  1994),  al- 
though the effect of the cap on mRNA export is less im- 
portant than in the case of the U  snRNAs. The nuclear 
CBC is a likely candidate for the mediator of this effect. 
However, a direct role for CBC in mRNA export has not 
been demonstrated. 
CBP20 and  CBP80 were  initially characterized in hu- 
man cells, but  homologues of both proteins  have  been 
identified in other organisms, including amphibia and in- 
sects. CBP20 is a highly conserved protein: the amino acid 
sequences of human and Xenopus CBP20 show 84% iden- 
tity (Izaurralde et al., 1995), while human and Drosophila 
CBP20 are  75%  identical, and Drosophila  CBP20 is  ef- 
ficiently  recognized  by  anti-human  CBP20  antibodies 
(Lewis, J., and I.W. Mattaj, unpublished data). Thanks to 
this high degree of conservation, we have been able to use 
polyclonal antibodies raised against the human CBP20 for 
in situ studies on insect polytene nuclei. In particular we 
have used the Balbiani ring system of Chironomus tentans 
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1994) to analyze in situ the association of CBC with pre- 
mRNA and mRNA during splicing and export. 
The Balbiani rings  (BRs)  of the dipteran Chironomus 
tentans (C.  tentans) are  puffs of exceptional size  in the 
polytene chromosomes of the larval salivary gland cells. 
Two large BRs, BR1 and BR2, can be easily identified on 
the polytene chromosomes. The pre-mRNA synthesized 
in BRI and BR2 is 35-40-kb long (75S RNA) and is pack- 
aged into large pre-mRNP  complexes, the  so-called BR 
RNP particles. The BR particles appear as abundant pre- 
mRNP complexes in the nucleoplasm of the salivary gland 
cells (Daneholt, 1982). Due to their structure and extraor- 
dinary dimensions, the BR RNP particles can be unambig- 
uously identified in  the  electron  microscope  (EM),  and 
their assembly, transport, and disassembly can be directly 
studied in situ (Skoglund et al., 1983; Mehlin et al.,  1992, 
1995). Nascent BR pre-mRNA molecules are rapidly pack- 
aged into growing RNP fibers that can be observed along 
the BR transcription units. As transcription progresses,  the 
growing RNP fibers gradually increase in length, and their 
distal portion becomes folded into a dense globular struc- 
ture (Skoglund et al., 1983).  When transcription is com- 
pleted, the  BR particles  are  released from the chromo- 
some and can be seen in the nucleoplasm as RNP granules 
of ~50 nm (Skoglund et al., 1896). The BR RNP granules 
are transported to the nuclear envelope, where they unfold 
and become elongated during translocation through the nu- 
clear pores (Mehlin et al., 1992). 
The BR pre-mRNA contains three introns close to the 
5' end (introns 1, 2, and 3) and one more intron (intron 4) 
located 30 kb downstream, close to the 3' end of the pre- 
mRNA (Wieslander and Paulsson, 1992).  Recent studies 
on the BR1 gene have shown that splicing may occur ei- 
ther cotranscriptionally or after transcription is completed, 
depending upon  the  position of the  introns  in  the  pre- 
mRNA  (Baur6n  and  Wieslander,  1994).  Intron  3  is  re- 
moved cotranscriptionally from most of the BR pre-mRNA 
molecules, and in situ studies have shown that spliceosome 
assembly/disassembly occurs rapidly on the nascent pre- 
mRNP fiber (Kiseleva et al., 1994). In addition, it has also 
been shown that most of the BR RNP particles located in 
the nucleoplasm are fully spliced (Baur6n and Wieslander, 
1994). 
The association of defined RNA-binding proteins with 
BR RNP  particles during successive stages of synthesis, 
maturation, and export can be directly visualized using im- 
muno-EM  methods  (Kiseleva  et  al.,  1994; Visa  et  al., 
1996). In this study, we analyze when the nuclear CBC is 
added to  the  pre-mRNP  complex.  It is well established 
that the formation of the 5' cap occurs cotranscriptionally 
(Salditt-Georgieff et al., 1980), but the time point at which 
CBPs  bind  to  the  5'  cap  has  not  previously  been  ad- 
dressed. The persistence of the association of CBC in fully 
spliced mRNP complexes in the nucleoplasm and during 
nucleo-cytoplasmic translocation is also examined. 
Materials and Methods 
Culturing Conditions 
C.  tentans was cultured as described by Lezzi et al.  (1981)  and salivary 
glands were isolated from fourth instar larvae.  C.  tentans  tissue culture 
cells were  grown in  suspension at 24°C as previously described  (Wyss, 
1982).  HeLa cells were grown on glass coverslips under standard condi- 
tions. For actinomycin D treatments, the cells were incubated in fresh me- 
dium containing actinomycin D  at a concentration of 5 ~g/ml for 70 min. 
Control cells were incubated in fresh medium without the drug. 
Antibodies 
Chironomus CBP20 was detected using affinity-purified rabbit antibodies 
raised against recombinant human CBP20 (Izaurralde et al., 1995). Preim- 
mune rabbit serum was used in parallel as negative control. Monoclonal 
antibody  9H10,  kindly  provided  by  G.  Dreyfuss, was  used  to  detect 
hnRNP A1.  Nuclear  pore  complex  (NPC)  proteins  were  labeled  with 
monoclonal antibody mAb414 (BAbCO, Richmond, CA). The secondary 
antibodies for immunofluorescence were  anti-rabbit  or anti-mouse im- 
munoglobulins conjugated to either TRITC or FITC (Boehringer Mann- 
heim, Mannheim, Germany). In immunoelectron microscopy experiments, 
the labeling was visualized using anti-rabbit IgG conjugated to 6-nm-col- 
loidal gold particles (Jackson ImmunoResearch Labs., West Grove, PA). 
Alkaline phosphatase--conjugated antibodies against rabbit immunoglob- 
ulins (DAKO A/S, Glostrup, Denmark) were used for Western blot anal- 
ysis and for immunostaining  of polytene chromosomes. 
Protein Electrophoresis and Western Blot Analysis 
C.  tentans tissue culture cells were washed in PBS, resuspended in TNM 
(10 mM triethanolamine-HCl buffer, pH 7.0, 100 mM NaC1, 1 mM MgCI2) 
containing 0.2%  NP-40 and 0.1  M  PMSF, homogenized in a glass tissue 
grinder with a tight-fitting pestle, and centrifuged at 2,000 g for 5 min at 
0°C. The supernatant was the cytoplasmic extract used for Western blot 
analysis. The pellet (nuclei) was washed with TNM, sonicated, and centri- 
fuged at 7,000 g for 10 min at 4°C. The supernatant was called RNP extract 
I. The pellet was resuspended in TNM, digested with 30 ng/ml RNase A 
for 10 min at room temperature, and centrifuged as before. The superna- 
tant of this last centrifugation together with RNP extract I constituted the 
nuclear protein extract used for Western blot analysis. Electrophoresis of 
proteins in SDS-PAGE was carried out using the minigel system (BioRad 
Labs, Richmond, CA).  Proteins were  electrophoresed  in  discontinuous 
gels (12% acrylamide in the separating gel) and blotted to transfer mem- 
branes (Immobilon PVDF, Millipore, Bedford, MA) using a  Trans-Blot 
semidry electrophoretic system (BioRad Labs). Membranes were blocked 
in PBS containing 10% dry milk powder and incubated with anti-CBP20 
antibody  (diluted  1:1,500  in  PBS  containing 1%  dry  milk  powder  and 
0.05%  Tween-20).  Labeling was visualized with  alkaline  phosphatase- 
conjugated  anti-rabbit  immunoglobulins using the  NBT/BCIP  system 
(Promega, Madison, WI) according to the manufacturer's instructions. 
Immunostaining of  Polytene Chromosome Squashes 
Squash preparations were made as described by Ericsson et al. (1990) with 
some modifications. The salivary glands were fixed with 4% paraformal- 
dehyde in PBS for 15-20 min and subsequently squashed in 45%  acetic 
acid. The slides were frozen in liquid nitrogen and the coverslips removed. 
The preparations were then washed extensively with PBS, blocked with 
2%  BSA in PBS, and incubated with affinity-purified anti-CBP20 anti- 
body diluted  1:500.  The secondary antibody was alkaline phosphatase- 
conjugated (DAKO A/S, Glostrup, Denmark), and the enzymatic reac- 
tion was developed using the NBT/BCIP system (Promega). The reaction 
was stopped by washing the slides in distilled water. The chromosomes 
were examined and photographed in a Standard microscope (Carl Zeiss, 
Oberkochen, Germany). For RNase treatments, chromosomes were pre- 
pared in the same manner but fixation was only for 5 min. After the glands 
were squashed and the coverslips removed, half of the slides were incu- 
bated in PBS (positive control) and the other half in PBS containing 100 
p,g/ml of preboiled RNase A  (Boehringer Mannheim) for 30 min at room 
temperature. The slides were  then washed in PBS, blocked,  and immu- 
nostained as above. 
Indirect Immunofluorescence 
Salivary glands were fixed for 1 h at room temperature in a solution of 4% 
paraformaldehyde in 0.1 M cacodylate buffer (pH 7.2), Fixed glands were 
rinsed in the same buffer, infiltrated in 2.3 M  sucrose and frozen by im- 
mersion  in  liquid  nitrogen.  Semithin  sections  (0.5-p~m-thick)  were  ob- 
tained in a  Reichert Ultracut S/FC S  ultramierotome system (Reichert, 
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glass slides. The sections were incubated in the following solutions: PBS 3 
x 5 min, PBSG (PBS containing 0.1 M glycine) for 5 min, 2% BSA in PBS 
for 20 min, primary antibody (either anti-CBP20 or preimmune serum) di- 
luted 1:500 in PBS supplemented with 0.2% BSA for 1 h, PBS 3 × 5 min, 
TRITC-conjugated  secondary antibody for 1 h, and PBS 3 × 5 min. 
HeLa ceils grown on coverslips were fixed with 3.7% paraformalde- 
hyde in CKS buffer (100 mM NaCI, 300 mM sucrose, 10 mM Pipes pH 6.8, 
3 mM MgCI2, 1 mM EGTA) for 10 min, permeabilized  with 0.5% Triton 
X-100 in CSK, and washed 3 ×  5 min in PBS. Double labeling was per- 
formed according to standard methods. To test the specificity of the im- 
munolabeling, the primary antibody was substituted by preimmune serum 
in the negative controls. 
Samples were examined and photographed in a Zeiss Axioskop fluo- 
rescence microscope. Confocal microscopy was performed as previously 
described (Ferreira et al., 1994) using the EMBL compact confocal micro- 
scope (Stelzer et al., 1991). 
Immunoelectron Microscopy 
Immuno-EM was performed according  to the procedure described  by 
Tokuyasu  (1980) with  minor modifications.  The specimens  were fixed 
with 4% paraformaldehyde and 0.1% glutaraldehyde  in 0.1 M cacodylate 
buffer (pH 7.2) for 20-25 min. Ultrathin cryosections were picked up on 
drops of 2.3 M sucrose and deposited on nickel grids coated with formvar 
and carbon. The sections were incubated  at room temperature in the fol- 
lowing solutions: PBSG for at least 30 min, 10% newborn-calf serum in 
PBS for 20 rain, first antibody (either anti-CBP20 purified  antibody  or 
preimmune serum diluted 1:100 or 1:500) for 1 h, PBSG (4 x 2 min), gold- 
conjugated secondary antibody (diluted 1:30 in PBSG supplemented with 
5% calf serum) for 1 h, and PBSG (4 x  2 min). After staining with 2% 
aqueous  uranyl acetate for 5-7 min, the grids were rinsed with distilled 
water and embedded in 4% poly vinyl alcohol (9-10 kD, Aldrich-Chemie, 
Steinheim,  Germany)  containing  0.4%  uranyl  acetate.  The  specimens 
were examined and photographed in a JEOL 100 CX microscope at 80 kV. 
Results 
Localization and Transcription-independent Nuclear 
Accumulation of CBP20 in HeLa Cells 
The localization of CBP80  in HeLa cells has  previously 
been reported (Izaurralde et al., 1994). CBP80 is found es- 
sentially  uniformly  distributed  throughout  the  nucleo- 
plasm and excluded from nucleoli, with a low amount of 
the protein being found in the cytoplasm. The distribution 
of CBP20 is similar (Fig. 1, a  and b). Like hnRNPA1 (Fig. 
1, c and d), CBP20  staining is observed in a punctuate  pat- 
tern  throughout  the  nucleoplasm,  but  not  in  nucleoli. 
While most of the  nucleoplasm  is  stained,  the  apparent 
concentration of CBP20 varies somewhat in different nu- 
cleoplasmic  regions.  There  is  no  detectable  increase  in 
CBP20 concentration at the nuclear periphery, i.e., in the 
region of the nuclear envelope. A small amount of CBP20 
Figure 1.  Localization and transcription-independent  nuclear ac- 
cumulation of CBP20 in HeLa cells. HeLa cells were grown in the 
absence (a-l) or presence (m-p)  of actinomyin D, and double la- 
beled with anti-CBP20 (red)  and  anti-hnRNP A1  (green)  anti- 
bodies. The intracellular distribution of both proteins during the 
cell cycle was analyzed by confocal microscopy. The localization 
of CBP20 and hnRNP A1 in nontreated cells during interphase is 
shown in a-b  and c-d,  respectively. During anaphase (e-f) and 
very early telophase (g-h)  both proteins are cytoplasmic. In late 
telophase (i-j), CBP20 is accumulated in the newly formed nuclei 
(red) while hnRNP A1 (green) is still in the cytoplasm. At the be- 
ginning of G1, both proteins are nuclear in nontreated cells (k-l), 
but in the presence of actinomycin D  (rn-n  and o-p)  CBP20 is 
nuclear while hnRNP A1 remains in the cytoplasm. In all cases, 
the immunofluorescence images (left)  are  accompanied by the 
corresponding phase contrast photographs (right). 
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ing  mitosis, both  CBP20  and  hnRNPA1  staining  is  seen 
throughout the cytoplasm (Fig.  1, e-h, e and f  showing a 
cell in anaphase, and, g  and h,  a  cell in early telophase). 
CBP20  reaccumulates  in  the  nucleus  before  hnRNPA1, 
and  at a  certain stage in late telophase, cells can be ob- 
served where the daughter nuclei stain strongly with anti- 
CBP20  antibodies  but  where  hnRNPA1  staining  is  con- 
fined to the cytoplasm (Fig. 1, i and j). The nuclei of early 
G1 cells stain for both antigens (Fig. 1, k and l). 
It has been reported  that  some proteins which  shuttle 
between the nucleus and cytoplasm accumulate in the nu- 
cleus  only  when  transcription  occurs  (Pifiol-Roma  and 
Dreyfuss, 1991). To determine whether CBP20 behaved in 
this way, we compared the reaccumulation of CBP20 and 
hnRNPA1 into daughter cell nuclei in the presence of the 
transcription  inhibitor  actinomycin  D.  Unlike  untreated 
cells (Fig. 1, k and l), cells which had been incubated in the 
presence of actinomycin D  did not show reaccumulation 
of hnRNPA1  (Fig.  1, m-p).  However, CBP20  accumula- 
tion in the nuclei of these cells was unaffected. CBP20 nu- 
clear accumulation is therefore not transcription dependent. 
Antibodies against Human CBP20 Recognize a Similar 
Protein in C. tentans 
We wished to study the nuclear distribution  of CBP20 in 
more detail,  and  in particular  to  examine its  association 
with nascent RNPs  and mRNPs undergoing  transport to 
the cytoplasm. The Chironomus salivary gland cell nuclei 
provide an excellent opportunity for such studies. To de- 
termine whether the  antibodies against the human CBPs 
could be used for in situ studies in  Chironomus,  we first 
probed Western blots of C. tentans extracts prepared from 
nuclear  and  cytoplasmic fractions  with  anti-CBP20  and 
anti-CBP80  antibodies.  The  antiserum  against  human 
CBP80  was  negative  (data  not  shown).  In contrast,  two 
different antisera raised against human CBP20 were posi- 
tive. Each reacted with a major band of the expected mo- 
bility (~18 kD) in C. tentans extracts. This 18-kD protein, 
presumably C.  tentans CBP20,  was the  only polypeptide 
recognized by the affinity-purified anti-CBP20 antibodies 
in C. tentans nuclear extracts (lane N in Fig. 2 and data not 
shown). The cytoplasmic extracts did not contain detect- 
able amounts of the 18-kD protein, but we sometimes ob- 
served a band of variable intensity at ~40 kD. This band 
was labeled weakly and in some extracts was undetectable 
(lanes C in Fig. 2). 
Next the intracellular distribution of the  18-kD protein 
in  C.  tentans was analyzed. For this purpose, indirect im- 
munofluorescence was performed on sections of C. tentans 
salivary glands using anti-CBP20 antibodies and a TRITC- 
conjugated secondary antibody. Some examples of the re- 
suits obtained are shown in Fig. 3, a  and b.  In agreement 
with the Western blot analysis reported above, the staining 
was predominantly nuclear.  Inside  the  nucleus,  both the 
nucleoplasm  and  the  chromosomes  were  labeled.  The 
staining was quite diffuse but nonuniform, and a banding 
pattern  was often  seen on  the  chromosomes.  Significant 
staining was also observed at the periphery of the nucleus. 
The  nucleoli  were  not  labeled.  The  nuclear  staining 
seemed to be highly specific as judged from the absence of 
Figure 2.  Specificity of anti-CBP20  antibod- 
ies  in  Western  blots  of C.  tentans proteins. 
Proteins  of C.  tentans nuclear (N) and cyto- 
plasmic (C) extracts were separated by SDS- 
PAGE and  blotted  to  transfer membranes. 
The membranes were cut into strips, and the 
strips  incubated with  affinity-purified  rabbit 
antibodies  against  human  CBP20. An  alka- 
line phosphatase-conjugated anti-rabbit IgG 
was used to detect the anti-CBP20  antibody. 
A major band of ~18 kD was seen in nuclear 
extracts (N) but was undetectable in cytoplas- 
mic extracts (C). The two lanes C correspond 
to  two  cytoplasmic  extracts  prepared  inde- 
pendently.  The  mobility  of molecular  mass 
standards is indicated on the left (kD). 
labeling in sections incubated with preimmune serum (Fig. 
3  c). The cytoplasm of the  salivary gland cells was often 
stained  above background  levels, but  we  could  not  con- 
clude from the present data whether this staining reflected 
the presence of CBP20 in the cytoplasm, or if it was due to 
cross-reactivity of the antibodies with the 40-kD polypep- 
tide  detected  in  the  Western  blots  (Fig.  2).  Both  anti- 
CBP20 antisera gave similar staining patterns, and the sec- 
ond antiserum also faintly recognized cytoplasmic protein 
on a Western blot (data not shown). In spite of the obvious 
differences  between  HeLa  cells  and  C.  tentans  salivary 
gland cells,  the  intranuclear  distribution  observed in  the 
two cell types was quite similar at a  gross level, the only 
major apparent differences being the ability to detect the 
polytene  chromosome  bands  and  the  intense  immuno- 
staining  at  the  periphery  of the  nucleus  of the  salivary 
gland  cells  (see  Discussion).  As  reported  above, CBP20 
was found in the nucleoplasm of HeLa cells in a relatively 
uniform distribution  (Fig.  1 a), and there was no obvious 
coimmunostaining with an antibody that stained NPC pro- 
teins (data not shown). 
In summary, the  results  reported above indicated  that 
the  antibodies  raised  against human  CBP20  recognize  a 
nuclear protein of N18-kD in C. tentans. The apparent mo- 
lecular mass of this  protein was as  expected for CBP20, 
and its intracellular distribution in C. tentans was very sim- 
ilar to that of CBP20 in HeLa cells (see also below). Taken 
together and considering the strong conservation of CBP20 
(see  Introduction),  these  observations  strongly  suggest 
that the 18-kD protein recognized by the antibodies in C. 
tentans is the homologue of human CBP20. 
CBP20 Is a Chromosomal Protein 
Proteins  that bind to nascent transcripts can be detected 
on  insect polytene  chromosomes using immunochemical 
methods  (e.g., Risau et al.,  1983).  As a  first approach to 
find out whether CBC binds to nascent RNA, we stained 
squash preparations of C.  tentans polytene chromosomes 
with affinity-purified anti-CBP20 antibodies.  An alkaline 
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salivary  gland  cells by indirect  immunofluo- 
rescence.  Semithin  cryosections  of  salivary 
gland  cells were stained  with  anti-CBP20  (a 
and b) or preimmune (c) antibodies. The anti- 
body-binding  sites  were  visualized  using  a 
TRITC-conjugated secondary antibody.  For 
each  section,  fluorescence  (left)  and  phase 
contrast  (right)  photographs  are  presented. 
Note that the labeling is mainly nuclear.  The 
nucleoplasm  and  the  chromosomes  are 
stained, while the nucleoli are negative. Faint 
labeling  is  observed in  the  cytoplasm with 
both anti-CBP20  and preimmune antibodies. 
N, nucleus; C, cytoplasm; Nu, nucleolus. The 
bar represents 20 txm. 
phosphatase-conjugated secondary antibody was used to 
visualize  the  immunoreactive  sites.  A  discrete  banding 
pattern  was  observed  in  chromosomes  incubated  with 
anti-CBP20 antibodies (Fig. 4, a and b) whereas no signifi- 
cant  immunoreactivity was  seen  with  preimmune  serum 
(Figs. 4, c and d). The BR puffs were strongly stained (see 
arrows in Fig. 4 a) and many other loci were also positive. 
This result  was not  surprising  considering  that  all  RNA 
polymerase II transcripts bear the 5' cap structure recog- 
nized by CBC, and previous immunocytochemical studies 
showed that  antibodies  against RNA polymerase II also 
give a high number of positive bands in Chironomus poly- 
tene chromosomes (e.g., Sass, 1982).  The same pattern of 
staining was obtained with two affinity-purified antibodies 
derived from different anti-CBP20 sera (data not shown). 
To establish that CBP20 binds to nascent transcripts and 
not  to  other  chromosomal components,  control  samples 
were digested with RNase A  before the immunostaining. 
The labeling intensity was heavily reduced in the RNase- 
treated controls (data not shown), which indicated that at 
least a major fraction of chromosomal CBP20 is bound to 
RNA.  This  type  of banded  staining  is  characteristic  of 
many  pre-mRNA-binding  proteins  (e.g.,  Amero  et  al., 
1992;  Matunis  et al.,  1992;  Kiseleva et al.,  1994),  and we 
concluded that the CBP20 binds to the nascent transcripts 
before they are released from the chromosomes. 
Binding of CBP20 to the 5' Domain of Nascent BR 
Pre-mRNP Particles 
For a  more detailed analysis of the binding of CBP20 to 
nascent RNA, we studied  the presence of CBP20 on the 
BR transcripts by immunoelectron microscopy. The active 
BR genes can be visualized in situ by electron microscopy 
as transcription units with well defined polarity (Skoglund 
et al., 1983).  As illustrated in Fig. 5 a, the nascent BR tran- 
scripts are packed continuously into RNP fibers of increas- 
ing  length  in  the  proximal  portion  of  the  transcription 
units.  In the middle and distal regions, the  5' domain of 
the growing RNP particles becomes packed into a  dense 
globular structure.  All along the BR genes, the morphol- 
ogy of the nascent BR RNP particles is indicative of their 
position in the transcription unit. 
The presence of CBP20  in  growing BR RNP particles 
was analyzed by immuno-EM  on  cryosections of whole- 
mount  salivary  glands  using  gold-conjugated  secondary 
antibodies.  In  spite  of  the  mild  fixation  conditions  re- 
quired to preserve the immunoreactivity, the morphologi- 
cal preservation was sufficient to enable the identification 
of growing BR particles in the proximal, middle, and distal 
portions of the BR genes. All portions of the transcription 
loops, from proximal to distal, were labeled to some ex- 
tent.  In particular,  abundant  immunogold  markers were 
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CBP20 in C. tentans polytene chro- 
mosomes.  Polytene  chromosome 
squashes  were  stained  with  anti- 
CBP20 antibodies  (a and b) or with 
preimmune serum  (c  and  d).  The 
antibody-binding  sites were visual- 
ized using an alkaline phosphatase- 
conjugated  secondary  antibody. 
Intense  anti-CBP20  staining  was 
observed in multiple  loci along the 
chromosomes (a and b) but not in 
the  negative  controls  (c  and  d). 
Chromosome  IV  (a  and  c)  and 
chromosome I (b and d) are shown 
as examples.  The arrows  in a indi- 
cate  the  location  of  BR  puffs  in 
chromosome  IV.  The  bar  repre- 
sents 20 ~m. 
seen in BR fibers located in the proximal region of the BR 
genes (Fig. 5, b and c). Comparison of labeled fibers with 
reconstructions of entire BR transcription loops (Masich, 
S.,  and  B.  Daneholt,  manuscript in  preparation)  showed 
that the dimensions and structure of the shortest growing 
particles with positive immunolabeling correspond to the 
RNP particles positioned in the proximal 5-10% of the ac- 
tive gene downstream from the promoter. As the time re- 
quired for the transcription of a BR gene is ~20 min (Egy- 
h~izi, 1975),  we conclude that the  CBP20 is added to the 
growing RNP in less than 2 min after the initiation of tran- 
scription. 
In the middle and distal portions of the BR transcription 
units, the terminal domain of the growing BR particle be- 
comes packed into a dense globular structure (Fig. 5 a). It 
has previously been shown that the formation of this glob- 
ular  structure  is  accompanied  by  major  changes  in  the 
folding of the basic RNP fiber, but the 5' end of the pre- 
mRNA always resides in the 5' (most distal) domain of the 
growing BR RNP particle (Skoglund et al., 1983; Mehlin et 
al.,  1992).  In the  immuno-EM experiments, we observed 
that the globular portions of the BR particles, but not their 
stalks, were significantly labeled (Fig. 5, d-g). The position 
of the gold markers was thus consistent with CBP20 being 
associated  with  the  5'  domain  of the  growing  BR  RNP 
particles. 
The introns located close to the 5' end of the BR pre- 
mRNA are spliced cotranscriptionally in most of the BR 
transcripts, and it has been estimated that the half-life of 
intron  3  is  ~2.5  min  of transcription  time  (Baur6n  and 
Wieslander,  1994).  Assuming similar values for introns  1 
and 2, all introns located close to the 5' end of the BR pre- 
mRNA have been removed from growing BR particles lo- 
cated in the distal part of the BR transcription units. Ac- 
cording to our immuno-EM data,  these  spliced particles 
still contain CBP20, which suggests that CBC remains on 
the RNP particles after splicing of introns close to the 5' 
end of the pre-mRNA. 
BR RNP Complexes during Export 
One of the  advantages of the  immuno-EM technique  on 
sections of whole-mount salivary glands was that we could 
study in  situ  not  only chromosomal RNPs  but  also  BR 
RNP  particles  in  the  nucleoplasm  and  at  the  NPCs.  As 
shown in Fig. 6, a-c, nucleoplasmic BR particles were sig- 
nificantly labeled by anti-CBP20 antibodies. These globu- 
lar particles are known to be mature BR RNPs released 
from the chromosome and probably in transit from the BR 
genes to the  NPCs.  Nucleoplasmic BR particles close to 
the nuclear envelope were also labeled (Fig. 6 d).  Apart 
from  BR  particles,  other  nucleoplasmic  structures  were 
also  recognized  by  the  antibodies.  In  particular,  gold 
markers were often associated with thin  fibrils that most 
probably  represent  transcripts  from  non-BR  genes  ex- 
pressed in the salivary glands. 
We next addressed whether CBP20 was still present in 
BR particles in  transit  to the  cytoplasm through  the  nu- 
clear pores.  It is  well documented  that  the  globular BR 
particles  become  elongated  upon  interaction  with  the 
NPC,  and  that they are translocated to the  cytoplasm as 
thick ribbons with the 5' end of the transcript in the lead 
(Mehlin  et al.,  1992,  1995).  In sections labeled with anti- 
CBP20 antibodies, we could often see gold markers deco- 
rating the leading end of translocating BR particles (Fig. 6, 
e-g). This observation strongly suggests that CBP20 is still 
attached to the 5' end of the transcript during nucleo-cyto- 
plasmic translocation. 
As  shown  by Western  blot  analysis  (Fig.  2),  the  anti- 
CBP20 antibodies can cross-react with a cytoplasmic pro- 
tein of ~40 kD. Although this cross-reactivity was found 
to be rather weak, we considered the possibility that the 
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BR RNP particles.  A schematic repre- 
sentation  of  the  active  BR  gene  is 
shown in a. Note the distinct morphol- 
ogy of the nascent BR RNP particles in 
the proximal (p), middle (m), and dis- 
tal (d) portions of the BR transcription 
unit. The binding of CBP20 to nascent 
BR particles was analyzed by immuno- 
EM.  Thin  cryosections  of  salivary 
glands  were  incubated  with  anti- 
CBP20  antibodies,  and  the  binding 
sites were visualized using a gold-con- 
jugated  secondary  antibody.  Signifi- 
cant immunolabeling  was  seen in  na- 
scent  BR particles  in all the segments 
of the active BR genes. Two examples 
of labeling in the proximal segment are 
shown in b and c. Four examples of la- 
beling in distal  BR RNP particles  are 
given in d-g. Some of the gold markers 
have been indicated by arrows. The bar 
represents 100 nm. 
labeling observed in the cytoplasmic end of the translocat- 
ing particles could be due to the 40-kD protein instead of 
being specific for CBP20. However, a detailed analysis of 
early translocation stages showed immunogold labeling in 
particles whose 5'  domain has not  yet reached the  cyto- 
plasm (e.g., Fig. 6 e). Since it seems unlikely that a  cyto- 
plasmic  protein  could  bind  the  RNP  particle  before  it 
traverses the pore, the labeling can most likely be attrib- 
uted to CBP20. The same results were obtained with affin- 
ity-purified antibodies from two independent  anti-CBP20 
sera.  Sections  incubated  in  parallel  with  the  preimmune 
sera  did  not  show  any  significant  labeling  (data  not 
shown).  From these results we conclude that CBC, or at 
least  CBP20,  remains  attached  to  the  5'  cap  of the  BR 
transcripts during nucleo-cytoplasmic transport. 
Discussion 
We have analyzed the association of the CBC with a spe- 
cific pre-mRNA particle, the BR RNP particle, at differ- 
ent stages of pre-mRNA synthesis and processing. This ap- 
proach  has  been  possible  thanks  to  the  recognition  by 
antibodies raised against the human CBP20 of the corre- 
sponding protein in C. tentans. A protein of 18 kD was rec- 
ognized in C. tentans nuclear extracts by two independent 
antibody  preparations  derived  from  two  different  sera 
against  human  CBP20.  The  cross-reativity of the  18-kD 
protein with anti-CBP20  antibodies, its mobility in  SDS- 
PAGE, its intracellular distribution in salivary gland cells, 
and its location at the 5' domain of the pre-mRNP parti- 
cles support the conclusion that the 18-kD protein is the C. 
tentans homologue to human CBP20. CBP20 is highly con- 
served  in  evolution.  Although  we  do  not  know  the  se- 
quence  of  Chironomus  CBP20,  human  and  Drosophila 
melanogaster  CBP20s  are  75%  identical  (Lewis,  J.,  and 
I.W. Mattaj, unpublished data). 
Antibodies raised against human CBP80 did not cross- 
react with any protein in C. tentans extracts, and therefore 
we could only detect one of the components of the nuclear 
CBC.  However,  studies  in  HeLa  cells  have  previously 
demonstrated  the  interdependence  between  CBP20  and 
CBP80.  The two proteins can be copurified to  apparent 
homogeneity  through  several  different  chromatographic 
columns,  and  are  coimmunoprecipitated  by  anti-CBP80 
antibodies.  Furthermore,  neither  CBP20  nor CBP80  can 
bind  detectably to  capped  RNA  in  the  absence of each 
other (Izaurralde et al., 1994,  1995).  Therefore, the local- 
ization described for CBP20 in the present study is likely 
to reflect the localization of the whole CBC. 
CBC and Pre-mRNP Splicing 
In vitro studies using HeLa nuclear extracts (tzaurralde et 
al., 1994), as well as microinjection experiments in Xeno- 
pus oocytes (Izaurralde et al., 1995), have shown that the 
nuclear CBC is involved in splicing of in vitro synthesized 
pre-mRNA molecules. The effect of the cap structure, and 
of CBC,  is  limited to the  5' proximal intron  of the  pre- 
mRNA (Ohno et al., 1987; Inoue et al., 1989; Lewis, J., E. 
Izaurralde, A. Jarmolowski, C. McGuigan, and I.W. Mat- 
taj,  manuscript  in  preparation).  It is  known  that  the  in- 
trons located close to the 5' end of the BR pre-mRNA are 
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during  nucleo-cytoplasmic  transport. Thin cryosections  of sali- 
vary glands were labeled with anti-CBP20 antibody followed by a 
gold-conjugated  secondary antibody.  Examples of BR RNP par- 
ticles in the nucleoplasm of the salivary gland ceils are given in 
a-c. The BR RNP particles  shown in d are located close to the 
nuclear  envelope (NE). Three examples of BR RNP particles in 
transit  through the nuclear pores are presented in e-g, and sche- 
matic interpretations of these translocating  particles are given un- 
der the micrographs. The arrows show the position of gold mark- 
ers in BR RNP particles. Note the labeling in the leading domain 
of the  translocating  particles  shown  in  e-g. The  photographs 
shown in d-g are oriented with nucleus (NUC) in the top part of 
the image and cytoplasm (CYT) in the bottom. The bar repre- 
sents 100 nm. 
excised cotranscriptionally (Baurrn and Wieslander, 1994; 
Kiseleva  et  al.,  1994).  According  to  these  observations, 
binding of the CBC to the 5' cap of the pre-mRNA is ex- 
pected to occur cotranscriptionally. The formation of the 
5' cap structure is an obvious prerequisite for binding and, 
in fact, the capping reaction is a very rapid event (Salditt- 
Georgieff et al., 1980; Rasmussen and Lis, 1993).  Our ob- 
servation that CBP20 is a chromosomal protein in C. ten- 
tans demonstrates that CBP20, and most likely CBC, binds 
to  nascent  RNA  molecules  before  transcription  is  com- 
pleted. 
Studies  in  different systems have indicated  that  the  5' 
cap is primarily required for efficient splicing of 5' proxi- 
mal introns (Ohno et al., 1987; Inoue et al., 1989; Lewis J., E. 
Izaurralde, A. Jarmolowski, C. McGuigan, and I.W. Mattaj, 
manuscript in preparation). Unfortunately, the exact kinet- 
ics of removal of the 5' proximal intron in the BR pre-mRNA 
(intron 1) is unknown.  However, the formation and disap- 
pearance of spliceosomes in the 5' region of the BR tran- 
scription unit take place within less than 5 min (Kiseleva et 
al., 1994), and intron 3 is known to be excised within 2.5 min 
after its transcription (Baur6n and Wieslander, 1994).  Con- 
sidering these obervations, it is reasonable to assume that 
splicing of intron 1 also occurs within the first few minutes 
of transcription.  Analysis of the  size and morphology of 
nascent BR RNPs suggests that CBP20 interacts with the 
pre-mRNP within 2 min after the start of transcription, which 
indicates that CBC binds to these transcripts before splic- 
ing begins, consistent with the proposed role of the nuclear 
CBC in cotranscriptional splicing of the 5' proximal intron. 
CBC and Pre-mRNP Export 
After  transcription  is  completed,  pre-mRNA  molecules 
are released to the nucleoplasm and must move to the nu- 
clear envelope. In the case of BR transcripts, it is known 
that most of the BR RNP particles located in the nucleo- 
plasm  are  fully  spliced  (Baurrn  and  Wieslander,  1994; 
Kiseleva et al., 1994). The results of our immuno-EM stud- 
ies have shown that many nucleoplasmic BR particles are 
labeled by anti-CBP20 antibodies, and from this observa- 
tion we conclude that the CBC remains attached to the 5' 
cap of the spliced BR RNP particles during transport from 
the chromosome to the nuclear envelope. 
The  indirect  immunofluorescence  on  C.  tentans  cells 
showed significant labeling at the nuclear periphery of the 
salivary gland cells, which raised the intriguing possibility 
that in these cells a fraction of CBP20 might be stably lo- 
calized at the nuclear envelope. However, double-labeling 
experiments performed in HeLa cells clearly showed that 
CBC was not concentrated at the nuclear envelope (Fig. 1 
and unpublished data). Because of this, and after examina- 
tion of the C. tentans nuclei by immuno-EM, we favor the 
explanation that the peripheral immunofluorescence seen 
in these nuclei is due to accumulation of BR RNP particles 
at  the  nuclear  envelope,  probably  due  to  rate-limiting 
events early in the process of translocation of these large, 
very abundant, RNPs. This interpretation is supported by 
the high density of BR RNP particles seen close to the nu- 
clear  envelope,  by  the  observation  that  these  BR  RNP 
particles are labeled by antibodies against CBP20, and by 
the fact that similar peripheral staining was seen using an- 
tibodies against Chironornus hnRNP proteins that associ- 
ate with BR RNPs (data not shown). 
In  relation  to  export  of mRNA,  the  most  interesting 
finding  is  the  presence  of CBP20  at  the  leading  end  of 
RNP particles that are being translocated through NPCs. 
In spite of technical limitations due to cross-reactivity of 
the anti-CBP20 antibodies used in this study with cytoplas- 
mic proteins, the labeling seen in BR RNP particles at the 
nuclear side of the nuclear envelope, as well as the pres- 
ence of CBP20 in early translocating particles whose 5' do- 
main is still located within the NPC, support the  conclu- 
sion that CBP20, and therefore probably CBC, is present 
in the RNP particles during nucleo-cytoplasmic transloca- 
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not be  taken  as  a  proof of functional significance.  How- 
ever,  together  with  previous  reports  that documented  a 
stimulation of mRNA  export rate  by the 5'  cap  (Hamm 
and  Mattaj,  1990;  Jarmolowski  et  al.,  1994),  our  results 
support an involvement of the CBC in export of mRNA. 
In  this  context,  it  is  noteworthy  that the  5'  end  of BR 
RNPs  is always in the leading end when BR RNAs  pass 
through NPCs (Mehlin et al., 1992). This raises the possi- 
bility  that  the  cap  structure  with  its  associated  proteins 
could be involved in the early recognition of the RNP par- 
tide at the pore complex or in the translocation process itself. 
Several reports from different laboratories (Rozen and 
Sonenberg,  1987;  Ohno  et  al.,  1990;  Izaurralde  et  al., 
1994), and also our present data, showed that CBP20 and 
CBP80  are  mainly nuclear proteins.  A  complex  of cyto- 
plasmic proteins that bind to the cap (elF-4F) that are dif- 
ferent  from  the  nuclear  CBC  has  been  characterized  in 
mammalian and yeast cells (for reviews see Shatkin, 1985; 
Rhoads,  1988; Sonenberg,  1988).  It is still an open ques- 
tion when elF-4F replaces nuclear CBC. A  fraction of elF- 
4E,  the  component  of  elF-4F  that  actually  binds  to  the 
cap, has recently been found in the cell nucleus (Lang et 
al., 1994), suggesting that elF-4E might bind to RNA be- 
fore it leaves the nucleus. However, our observation is that 
the nuclear CBC is exported as part of the BR RNP parti- 
cle, making exchange on the cytoplasmic side of the NPC 
more probable. 
The  immuno-EM  study  indicated  that  CBC  is  trans- 
ported to and through the NPC, although we cannot defin- 
itively say whether the complex is released from the distal 
side of the NPC into the cytoplasm. Taken together, these 
observations suggest that the nuclear CBC is reimported 
into the nucleus rapidly after leaving the RNP particle. No 
experiments  have been done so far to determine  directly 
whether CBC exhibits shuttling behavior, but our experi- 
ments  on  actinomycin  D-treated  cells  show  that, unlike 
the prototypical shuttling hnRNP protein hnRNPA1, nu- 
clear  localization  of  CBC  does  not  depend  on  ongoing 
transcription. CBP80 carries a functional nuclear localiza- 
tion signal (Izaurralde et al., 1994, 1996; Weis et al., 1995), 
and the nuclear CBC could therefore be reimported to the 
nucleus via the canonical NLS-dependent pathway, i.e., in 
a way that would be independent of transcription. 
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